Can a chest scan shortcut dangerous heart rhythm surgery?

NCT ID NCT07759427

First seen Aug 12, 2026 · Last updated Aug 13, 2026 · Updated 1 time

Summary

This trial tests whether a non-invasive mapping system called VIVO can help doctors locate the source of a dangerous heart rhythm called ventricular tachycardia (VT) before an invasive procedure. Patients with structural heart disease who need catheter ablation will be randomly assigned to receive either standard ablation or VIVO-guided ablation. The goal is to see if VIVO reduces procedure time and improves efficiency, while also assessing safety and patient outcomes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
VIVO-assisted mapping, a non-invasive cardiac mapping technology used to guide catheter ablation for ventricular tachycardia
What this could lead to
If successful, this approach could make VT ablation faster, safer, and more efficient, potentially improving outcomes for patients with structural heart disease.
What could go wrong
The trial is relatively small and early, and the benefit may not be confirmed. The procedure still involves invasive ablation, which carries risks like bleeding or heart damage.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CATHETER ABLATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Royal Sussex County Hospital

    NOT_YET_RECRUITING

    Brighton, BN2 1ES, United Kingdom

  • The James Cook University Hospital

    RECRUITING

    Middlesbrough, TS4 3B, United Kingdom

  • University Hospitals Coventry and Warwickshire

    RECRUITING

    Coventry, CV2 2DX, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.